University of Utah Annual IRB Member Training Ann Johnson, PhD Associate Director Institutional Review Board

Size: px
Start display at page:

Download "University of Utah Annual IRB Member Training Ann Johnson, PhD Associate Director Institutional Review Board"

Transcription

1 University of Utah Annual IRB Member Training 2016 Ann Johnson, PhD Associate Director Institutional Review Board

2 Overview of NIH policy on the use of a Single IRB for multi site research (and other federal thoughts) Overview of sirb premise and process Overview of the NCATS TIC grant and what that means for Utah Plans moving forward

3 Final NIH Policy on the Use of a Single Institutional Review Board for Multi Site Research available online Requires the use of a single IRB for multi site research funded by the NIH Applies to all competing grant applications received on or after May 25, 2017

4 The goal of this policy is to enhance and streamline the IRB review process in the context of multi site research so that research can proceed as effectively and expeditiously as possible. Eliminating duplicative IRB review is expected to reduce unnecessary administrative burdens and systemic inefficiencies without diminishing human subjects protections. The shift in workload away from conducting redundant reviews is also expected to allow IRBs to concentrate more time and attention on the review of single site protocols, thereby enhancing research oversight.

5 Ancillary Reviews Qualifications & Training Compliance & Oversight Human Research Protection Program Conflict of Interest IRB HIPAA Privacy Board

6 Reliance agreement execution Outline the roles and responsibilities between the sirb and the local site Attempts to standardize and streamline Initial sirb review + local review Bringing review times to the mean Ongoing review and monitoring by sirb and locally Continuing reviews, amendments, report forms, auditing

7 Investigator and study team Human Research Protection Program (HRPP) Local IRB Local Conflict of Interest Review Local ancillary committees Local training and compliance

8 How do I interact with the CIRB? What is the communication plan? What does the CIRB expect of me? What requirements does my institution have that are not covered by CIRB review? How do I continue to meet those requirements? Do policies of the CIRB differ from policies of my local IRB and institution? How do I adhere to both sets of policies?

9 What are the terms and conditions of the Reliance Agreement with the CIRB? What are our responsibilities as the local HRPP? What local context concerns, state laws, institutional policies apply to this protocol? How do we communicate this to the CIRB? How do we confirm these local requirements are met? How do ancillary committee reviews get completed our institution? How do we track this protocol as a research project happening at our institution? How do we handle problems that occur at our research site?

10 1. Investigator submits the protocol and associated documents for facilitated review at the local site. Is this a single application to a coordinating body, or separate applications to different groups and committees? 2. All applicable groups/committees review the protocol and documents. A coordinating body for facilitated review? Perhaps. Conflict of interest review Legal review Scientific review Funding and billing review Resources review Etc.

11 3. Groups/Committees provide feedback on the protocol and documents. This may include revisions that need to be made locally or to the overall study 4. Investigators address local feedback and revisions. 5. Feedback and revisions for the overall study are sent to the CIRB. Does the coordinating body do this, or the investigator?

12 There is likely to be an overall consent (and authorization) document for the study. The local site should be able to add local language to key sections. Person to Contact Research Related Injury Statement HIPAA Authorization Others, depending on state law and local policies The investigator should fill this in as part of the initial facilitated review. The local groups/committees should verify it is correct and meets requirements.

13 1. CIRB reviews the overall study and makes appropriate determinations. 2. CIRB reviews the local requirements, feedback, and revisions, ensuring these are addressed and incorporated. 3. CIRB issues approval of the study and of participation of the local site. The CIRB may do all of this as part of an initial review of the study OR may consider the local site as part of an amendment.

14 1. The investigator provides CIRB approval documentation and the final version of the approved documents to the local groups/committees. 2. The groups/committees verify the approval and send a facilitated review acknowledgement. 3. The investigator may begin the research at the local site.

15 Local IRB review may still be required for certain determinations; refer to the terms and conditions of the Reliance Agreement. Local amendments HIPAA determinations Consent documents Shared IRB Reviews would likely have a different process to facilitate the review

16 Gathering all necessary information efficiently Using all necessary information meaningfully Multiple electronic systems Communication barriers Standardizing key policies and processes Collecting reliable and valid metrics Improving review times

17 Funded by the National Center for Advancing Translational Sciences Works in collaboration with the national CTSAs Goal to accelerate the translation of novel interventions to evidence based treatment

18 Three awards: University of Utah Johns Hopkins & Tufts collaboration Vanderbilt & Duke collaboration The three centers will work together to develop processes for sirb model Master contracts Streamline protocol design and procedures Patient engagement

19 Review same components, but for multiple sites Collect local context and review documentation for use by the staff and convened board Provide sirb specific documentation to local sites Open up ERICA to outside users

20 Need for local SOPs on how to defer to a CIRB and complete local facilitated review requirements. Need to consider how CIRB review interplays with local electronic systems and submission processes. Need to have a plan for training and informing research teams and HRPP officers on how to complete local processes for facilitated review. Need to have a plan for ensuring research teams understand differences between CIRB policy and local policy. Need for local SOPs for monitoring compliance at the local site.

21 Update ERICA to allow for better indication of sirb use Electronically track reliance agreements and connect that system to ERICA Educate the research community! Develop guidance and instruction documents Work with TIN partners and other academic institutions to develop best practices and standardizations Engage with multiple institutions to become a more prolific sirb Measure metrics

22 Question & Comments? Thank you!

External IRB Review What Does it Mean for Your Institution

External IRB Review What Does it Mean for Your Institution External IRB Review What Does it Mean for Your Institution Wesley G Byerly, Pharm.D. Associate Vice President for Research Integrity and Regulatory Affairs University of Connecticut and UCONN Health HCCA

More information

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients

More information

RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH

RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH 1. Overview RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH The ethical and regulatory requirements of The Ohio State University Human Research Protection Program (HRPP) apply to all research

More information

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework 1 Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework Mandy Morneault Research Compliance Monitor University of Washington Institute of Translational Health

More information

CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK

CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK What Do They Have in Common? Hammer M. Harvard Business Review, 2004. What Do They Have in Common?

More information

Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation.

Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation. Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation. Carolinas Collaborative Pilot RFA Webinar May 8, 2017 Partners Overview

More information

2018 Common Rule Implementation Checklist

2018 Common Rule Implementation Checklist 2018 Common Rule Implementation Checklist High Priority Action Items The following table outlines certain actions institutions should consider taking ahead of the 2018 Common Rule s effective and general

More information

Expanded Access and the Individual Patient IND

Expanded Access and the Individual Patient IND Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office

More information

Doing Human Subjects Research? Changing NIH Policies May Impact You

Doing Human Subjects Research? Changing NIH Policies May Impact You Doing Human Subjects Research? Changing NIH Policies May Impact You Reforms & Initiatives To enhance the stewardship of research involving human subjects, NIH is implementing the following: All Research

More information

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS Catherine Jahrsdorfer, R.N., B.S.N. Director of Clinical Services Office of Clinical Research January 2 & 3, 2012 Learning

More information

Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS

Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Presentation Outline What is human subjects research? What are the reasons for IRB review? What is exempt from

More information

Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013

Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Basic Laboratory Research Clinical Research Improved Public Health Translational Research Population Research Basic

More information

June 7, Harold E. Varmus, MD Director National Cancer Institute 31 Center Drive Building 31 Room 11A48 MSC 2590 Bethesda, Maryland

June 7, Harold E. Varmus, MD Director National Cancer Institute 31 Center Drive Building 31 Room 11A48 MSC 2590 Bethesda, Maryland Harold E. Varmus, MD Director National Cancer Institute 31 Center Drive Building 31 Room 11A48 MSC 2590 Bethesda, Maryland 20892-2590 Dear Harold: Thank you, again, for taking the time to come to ASCO

More information

Streamlining IRB Procedures for Expanded Access

Streamlining IRB Procedures for Expanded Access Streamlining IRB Procedures for Expanded Access Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation Richard Klein Director, FDA Patient Liaison Program Office of Health and Constituent Affairs

More information

Office for Human Subject Protection. University of Rochester

Office for Human Subject Protection. University of Rochester POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,

More information

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH Investigators Responsibility #1: Design and Implement Ethical Research Consistent with the Three Ethical Principles Delineated in The Belmont Report. The Belmont Report: Three Basic Ethical Principles:

More information

Advancing the Use of Central IRBs for Multicenter Clinical Trials

Advancing the Use of Central IRBs for Multicenter Clinical Trials Advancing the Use of Central IRBs for Multicenter Clinical Trials Cynthia Hahn, Chief Operating Officer, The Feinstein Institute for Medical Research July 10, 2015 CTTI Mission To identify and promote

More information

Rules of Human Experimentation

Rules of Human Experimentation Rules of Human Experimentation Elaine Larson CUMC IRB Chair Associate Dean for Research, School of Nursing Professor of Epidemiology, Mailman School of Public Health Oversight for Human Research Office

More information

POLICY AND PROCEDURES ON SURVEY ADMINISTRATION UNC ESHELMAN SCHOOL OF PHARMACY

POLICY AND PROCEDURES ON SURVEY ADMINISTRATION UNC ESHELMAN SCHOOL OF PHARMACY POLICY AND PROCEDURES ON SURVEY ADMINISTRATION UNC ESHELMAN SCHOOL OF PHARMACY THE IMPORTANCE OF SURVEYS Approved, December 20, 2012 A survey is a systematic method of collecting data from a population

More information

Human Research Protection Program Guidance for Human Research Determination

Human Research Protection Program Guidance for Human Research Determination Human Research Protection Program Guidance for Human Research Determination I.1.A The sole purpose of the Institutional Review Board (IRB), as defined in federal statutes, is the protection of human subjects

More information

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the

More information

The Clinical Research Regulatory Process

The Clinical Research Regulatory Process The Clinical Research Regulatory Process Understanding the Impact A CenterWatch-Complion Survey by Rick Arlow, Founder and CEO Complion Inc. Introduction The importance of data validity obtained from a

More information

Ethical, Political and Social Issues in Joint Ethics Review: Lessons from the Indiana University/Moi University Academic Research Ethics Partnership

Ethical, Political and Social Issues in Joint Ethics Review: Lessons from the Indiana University/Moi University Academic Research Ethics Partnership Ethical, Political and Social Issues in Joint Ethics Review: Lessons from the Indiana University/Moi University Academic Research Ethics Partnership Eric M. Meslin, Ph.D. Director, Indiana University Center

More information

WHAT IS OUR RESEARCH PORTFOLIO?

WHAT IS OUR RESEARCH PORTFOLIO? Clinical Research Management System Online Collaborative Research Environment (OnCore) Forte Research Systems Christian Stephens Office of Research Informatics Project Manager Mike Neuenfeldt Forte Project

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria Question 1: What laws or regulations apply to an application for conducting a clinical

More information

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates

More information

The Research Services Organization (RSO) of the Academic Health Center

The Research Services Organization (RSO) of the Academic Health Center Annual Report 2005 The Research Services Organization (RSO) of the Academic Health Center A Summary of the Eighth Year of Operations Submitted by: Mark S. Paller, M.D., M.S. Director, Research Services

More information

1 The Clinical Research Coordinator (CRC)... 1

1 The Clinical Research Coordinator (CRC)... 1 TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...

More information

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way.

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way. Name and Clinic Number IRB # 08-007049 00 Consent form approved July 16, 2015; This consent valid through July 15, 2016; 1. General Information About This Research Study Study Title: Mayo Clinic Biobank

More information

SITE SUBMISSION FORM (SINGLE SITE)

SITE SUBMISSION FORM (SINGLE SITE) *We accept study submissions by email, fax or mail. 1. STUDY INFORMATION A. Sponsor: Protocol.: Study Title: B. Study Type: Drug, Biologic or Dietary Supplement (please complete section C., then proceed

More information

Tier Assessment/Setting - Quick Guide to Competency Levels

Tier Assessment/Setting - Quick Guide to Competency Levels Tier Assessment/Setting - Quick Guide to Competency Levels RESEARCH OPERATIONS Competency Fundamental Skilled Advanced Interactions with IRB Candidate has used the system to successfully submit documents

More information

Trends in Oversight of Human Research Protections?

Trends in Oversight of Human Research Protections? Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for

More information

Protection of Research Participants: The IRB Process and the Winds of Change

Protection of Research Participants: The IRB Process and the Winds of Change Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick

More information

RECRUITING OF AND ADVERTISING FOR SUBJECTS

RECRUITING OF AND ADVERTISING FOR SUBJECTS 1. POLICY Steering Committee approved 9/19/11 The informed consent process begins when a potential human research subject first learns of a study, which is usually accomplished through recruitment efforts.

More information

Recruitment of Subjects Best Practices

Recruitment of Subjects Best Practices UCLA CTSI WELCOME TO ONLINE TRAINING FOR CLINICAL RESEARCH COORDINATORS ROLE OF THE RESEARCH COORDINATOR Recruitment of Subjects Best Practices May 2016 Objectives Definitions Goals and Barriers Recruitment

More information

Standard Operating Procedures (SOPs)

Standard Operating Procedures (SOPs) Organizational Strategies for Clinical Trials Standard Operating Procedures (SOPs) SUSAN JACKSON, MPA UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE UNC CENTER

More information

Clinical Research at MSU

Clinical Research at MSU Financial Administration Development Program: Clinical Research at MSU Kristen Burt, Office of Regulatory Affairs (ORA) Sharon Schooley, Clinical & Translational Sciences Institute (CTSI) February 24,

More information

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form A. Demographic Information Date of Submission: Reason for Submission: New Project Response to Comments Reconsideration Disapproval

More information

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network 1.0 Leadership and Decision-Making When reading this document it is important to note that there are several categories

More information

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no: Research as a Participating site STANDARD OPERATING PROCEDURE FOR OVERSIGHT SOP No: P08/PF2 V2 Effective Date: 31 st July 2013 Supersedes: P08/PF2 Revision Date: 31 st March 2014 Author: Position: Approved

More information

Quality Assurance in Clinical Trials

Quality Assurance in Clinical Trials Quality Assurance in Clinical Trials Doctor Catherine CORNU, Lyon clinical Investigation Centre EUDIPHARM December 5th, 2011 1 Introduction: quality in clinical research in human subjects Regulatory requirements:

More information

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE CANCER CENTER SCIENTIFIC REVIEW COMMITTEE The Clinical Scientific Review Committee (SRC) at The Medical College of Wisconsin Cancer Center plays a vital role in protocol review and monitoring to ensure

More information

Creating, Managing and Delivering Regulated Content in Pharma. Jim Nichols VP, US Operations & Life Sciences DitaExchange Inc.

Creating, Managing and Delivering Regulated Content in Pharma. Jim Nichols VP, US Operations & Life Sciences DitaExchange Inc. Creating, Managing and Delivering Regulated Content in Pharma Jim Nichols VP, US Operations & Life Sciences DitaExchange Inc. DitaExchange simplifies the way organizations Create Manage Deliver Re-use

More information

Human Subjects Protection: Training for Research Teams

Human Subjects Protection: Training for Research Teams Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center

More information

Dr. David D. Lee, Provost and VP for Academic Affairs

Dr. David D. Lee, Provost and VP for Academic Affairs POLICY & PROCEDURE DOCUMENT NUMBER: 2.7000 SECTION: TITLE: Research Institutional Biosafety Committee Policy DATE: November 6, 2017 Authorized by: Dr. David D. Lee, Provost and VP for Academic Affairs

More information

Audit Committee Presentation FY2011 Audit Plan (annual risk assessment) August 16, 2010

Audit Committee Presentation FY2011 Audit Plan (annual risk assessment) August 16, 2010 Audit Committee Presentation FY2011 Audit Plan (annual risk assessment) August 16, 2010 INTERNAL AUDITS ACADEMIC ENTERPRISE Are research and development expenses expended in accordance with the terms of

More information

Assistant Business Manager Job Description

Assistant Business Manager Job Description Assistant Business Manager Job Description Responsible to: Responsible for: Business Manager Admin Team made up of: Attendance and Admission Officer Admin Assistant x2 Business Administration Apprentice

More information

TMF Reference Model. Topline results of 2014 TMF Survey #4. August 2014 Fran Ross TMF Survey Sub-team

TMF Reference Model. Topline results of 2014 TMF Survey #4. August 2014 Fran Ross TMF Survey Sub-team TMF Reference Model Topline results of 2014 TMF Survey #4 August 2014 Fran Ross TMF Survey Sub-team Trial Master File (TMF) Survey Background TMF Survey purpose: industry-wide, gather insight into quality,

More information

Related Donor Informed Consent to Participate in Research

Related Donor Informed Consent to Participate in Research Related Donor Informed Consent to Participate in Research This is an informed consent document for a research study that your family member is participating in. This document will inform you about the

More information

April 13, Background

April 13, Background Pfizer Inc 235 East 42nd Street New York, NY 10017-5755 Tel 212 733 4210 Fax 646 383 9249 Email: marc.wilenzick@pfizer.com April 13, 2009 http://www.regulations.gov Christine Ireland Committee management

More information

New NIH Clinical Trial Requirements for Grants & Contracts 2017/2018

New NIH Clinical Trial Requirements for Grants & Contracts 2017/2018 New NIH Clinical Trial Requirements for Grants & Contracts 2017/2018 Changes in Human Subjects Research Grant Application Process Clinical Trial Applications IRB Single IRB Certificates of Confidentiality

More information

Contents. Connected Competence Q&A June 2017

Contents. Connected Competence Q&A June 2017 Connected Competence Q&A June 2017 Contents Introduction to Connected Competence... 2 What is Connected Competence?... 2 How does it work?... 2 Which organisations have adopted Connected Competence?...

More information

NIH Clinical Trials Updates: Putting it All Together. Why the changes to NIH-funded studies involving human subjects?

NIH Clinical Trials Updates: Putting it All Together. Why the changes to NIH-funded studies involving human subjects? NIH Clinical Trials Updates: Putting it All Together Sherry Mills, MD MPH Director Office of Extramural Programs Office of Extramural Research NIH 1 Why the changes to NIH-funded studies involving human

More information

CTTI Overview One Decade of Impact. One Vision Ahead.

CTTI Overview One Decade of Impact. One Vision Ahead. Feb. 6, 2018 CTTI Overview One Decade of Impact. One Vision Ahead. Pamela Tenaerts, MD, MBA Executive Director #CelebrateCTTI Discover how CTTI has influenced the clinical trials enterprise during the

More information

Role of the IRB in Human Subjects Research

Role of the IRB in Human Subjects Research Role of the IRB in Human Subjects Research Richard D. Stevenson, M.D. Chair Institutional Review Board for Health Sciences Research (IRB-HSR) University of Virginia Office of the Vice President for Research

More information

Rare Diseases: Challenges and Opportunities NIH Perspective

Rare Diseases: Challenges and Opportunities NIH Perspective Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes

More information

NIH funded Human Subjects Research/Clinical Trials and the Transition to Forms E. How Do Changing NIH Policies Impact Me?

NIH funded Human Subjects Research/Clinical Trials and the Transition to Forms E. How Do Changing NIH Policies Impact Me? NIH funded Human Subjects Research/Clinical Trials and the Transition to Forms E How Do Changing NIH Policies Impact Me? LCOM Informational Sessions Nov. 14, 16 2017 Jeralyn Haraldsen, PhD Grant Proposal

More information

MODULE I: MEDICARE & MEDICAID GENERAL COMPLIANCE TRAINING

MODULE I: MEDICARE & MEDICAID GENERAL COMPLIANCE TRAINING MODULE I: MEDICARE & MEDICAID GENERAL COMPLIANCE TRAINING 2 0 1 4 A Message From Our CEO and Compliance Officer At PacificSource, we pride ourselves on maintaining a culture of compliance and high ethical

More information

GW Policy on Human Research Protection Program

GW Policy on Human Research Protection Program GW Policy on Human Research Protection Program 1. PURPOSE 1.1. This policy establishes the [Organization] s Human Research Protection Program (HRPP) and its commitment to protect the rights and welfare

More information

Researcher Data Security Self- Assessment Questionnaire for Existing Studies

Researcher Data Security Self- Assessment Questionnaire for Existing Studies Researcher Data Security Self- Assessment Questionnaire for Existing Studies Version 1.0 October 2016 Researcher Data Security Program Self- Assessment Questionnaire for Existing Studies Purpose The Harvard

More information

The University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit. Internal Audit Report 14:07

The University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit. Internal Audit Report 14:07 Office of Internal Audit The University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit Internal Audit Report 14:07 November 17, 2014 Table of Contents I. Executive Summary

More information

Trial oversight SOP for HEY-sponsored CTIMPs

Trial oversight SOP for HEY-sponsored CTIMPs R&D Department Trial oversight SOP for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored in a retrieval system

More information

THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION

THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices

More information

Oracle. Talent Management Cloud Using Talent Review and Succession Management. Release 12. This guide also applies to on-premises implementations

Oracle. Talent Management Cloud Using Talent Review and Succession Management. Release 12. This guide also applies to on-premises implementations Oracle Talent Management Cloud Using Talent Review and Succession Management Release 12 This guide also applies to on-premises implementations Oracle Talent Management Cloud Part Number E73312-04 Copyright

More information

NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information

NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information This document is scheduled to be published in the Federal Register on 09/21/2016 and available online at https://federalregister.gov/d/2016-22379, and on FDsys.gov [BILLING CODE 4140-01-P] DEPARTMENT OF

More information

What is an IRB (Institutional Review Board)?

What is an IRB (Institutional Review Board)? What is an IRB (Institutional Review Board)? The Belmont Report The Belmont Report on the Ethical Principles and Guidelines for the Protection of Human Subjects of Research was prepared by the National

More information

Learn More: Protecting Human Subjects Participating in Research and their Personal Privacy + NIH Clinical Trial & Common Rule Updates

Learn More: Protecting Human Subjects Participating in Research and their Personal Privacy + NIH Clinical Trial & Common Rule Updates RESEARCH ADMINISTRATION November 2017 Northeastern University Learn More: Protecting Human Subjects Participating in Research and their Personal Privacy + NIH Clinical Trial & Common Rule Updates Learning

More information

Data Governance Implementation

Data Governance Implementation Service Offering Implementation Leveraging Data to Transform the Enterprise Benefits Use existing data to enable new business initiatives Reduce costs of maintaining data by increasing compliance, quality

More information

Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center

Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center Office of Research Compliance and Quality Assurance Yolanda P. Davis Sr. Research Compliance Officer Author: Yolanda P.

More information

Research Job Summaries

Research Job Summaries Job Summaries Job 32713 32712 32711 32613 32612 32611 32516 32515 32514 32513 32512 32511 Chief Officer Deputy Chief Officer Senior Officer Officer The Chief Officer (CRO) serves as an integral member

More information

SAMPLE Marketing Slides for Building a Compliance Program

SAMPLE Marketing Slides for Building a Compliance Program SAMPLE Marketing Slides for Building a Compliance Program Compliance Mission A central organization that integrates compliance programs and provides oversight to existing programs to provide a reasonable

More information

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee) Page 1 of 8 Hospital Authority (HA) Guide on Research Ethics (for Study Site & Version Effective Date 2 01/02/2015 Document Number HAHO-CE&TM-HA REC Author HA Head Office Steering Committee on Research

More information

APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1

APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1 APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD Revised January 2010 Page 1 The IRB Proposal Includes: 1. All documents, other than the informed consent form, should be understandable to an informed

More information

Report on recognising organisations as awarding bodies

Report on recognising organisations as awarding bodies Report on recognising organisations as awarding bodies The recognition process February 2008 QCA/08/3569 Contents The recognition process... 3 Background... 3 Current recognition process... 3 Reducing

More information

Investigator Manual. Human Subjects Protection Program

Investigator Manual. Human Subjects Protection Program Human Subjects Protection Program HRP-103, Revised June 1, 2015 HRP-103 06/01/2015 2 of 33 Table of Contents Scope... 3 What is the purpose of this manual?... 3 What is Human Research?... 3 What is the

More information

Regulatory Change Management

Regulatory Change Management Regulatory Change Management Maturity Model: From Ad Hoc to Agile November 2015 Michael Rasmussen, J.D., GRCP, CCEP The GRC Pundit @ GRC 20/20 Research, LLC OCEG Fellow @ www.oceg.org Change is the Greatest

More information

How Data Managers Support Prospective Research

How Data Managers Support Prospective Research How Data Managers Support Prospective Research CIBMTR Data Managers Meeting February 20, 2018 Hati Kobusingye & Deborah Mattila Prospective Clinical Research Agenda Background - Prospective Research (RCI

More information

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED?

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? 50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? Kevin L. Nellis, MS, CIP Executive Director, Human Research Protections and Quality Assurance Kathleen E. Powderly, CNM, PhD Director, John Conley

More information

ITSM Process/Change Management

ITSM Process/Change Management ITSM Process/Change Management Process Documentation Revision Date: December 13, 2017 Version Number: 2.0 Document Ownership Document Owner Maury Collins Revision History ITSM Role, Department Service

More information

MONITORING AND REPORTING (ARTICLE

MONITORING AND REPORTING (ARTICLE CBD Distr. LIMITED UNEP/CBD/NP/COP-MOP/1/L.10 16 October 2014 IGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY SERVING AS THE MEETING OF THE PARTIES TO THE NAGOYA PROTOCOL

More information

PARTNERS HUMAN RESEARCH COMMITTEE. Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review

PARTNERS HUMAN RESEARCH COMMITTEE. Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review PARTNERS HUMAN RESEARCH COMMITTEE Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review For the purposes of this Primer, tissue is defined as any biological specimen obtained

More information

Professor Mervyn King Chairman International Integrated Reporting Council Submitted via

Professor Mervyn King Chairman International Integrated Reporting Council Submitted via Professor Mervyn King Chairman International Integrated Reporting Council Submitted via www.theiirc.org/consultationdraft2013 15 July 2013 Dear Professor King, Consultation draft of the International

More information

ESRC Research Ethics Framework - Frequently Asked Questions (FAQs)

ESRC Research Ethics Framework - Frequently Asked Questions (FAQs) ESRC Research Ethics Framework - Frequently Asked Questions (FAQs) The following FAQs reflect typical questions asked of the ESRC Research Ethics Framework (REF). Where appropriate, reference is made to

More information

HR/Payroll Shared Services Service Level Agreement. December 1, 2017

HR/Payroll Shared Services Service Level Agreement. December 1, 2017 HR/Payroll Shared Services Service Level Agreement December 1, 2017 Table of Contents Purpose... 2 Future reviews and amendments to this Service Level Agreement... 2 Objectives of the Service... 2 Service

More information

Efficiency. Purpose of the Checklist. Description

Efficiency. Purpose of the Checklist. Description Efficiency Purpose of the Checklist To guide and support public procurement practitioners in reviewing, developing and updating their procurement framework, according to the 12 principles of the Recommendation

More information

Implementation Life-cycle SOP

Implementation Life-cycle SOP 1.0 Commercial in Confidence 11-Aug-2006 1 of 12 Implementation Life-cycle SOP Document No: H4_SOP_0100 Prepared by: David Brown Date: 11-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 11-Aug-2006

More information

Patient Handbook on Stem Cell Therapies

Patient Handbook on Stem Cell Therapies Patient Handbook on Stem Cell Therapies WWW.ISSCR.ORG WWW.CLOSERLOOKATSTEMCELLS.ORG Patient Handbook on Stem Cell Therapies Introduction We have all heard about the extraordinary promise that stem cell

More information

The long anticipated draft of the FDA s

The long anticipated draft of the FDA s This article provides an overview of the draft guidance, the key changes in relation to the 1987 guidance, and reviews its potential impact on the current industry approaches to science- and risk-based

More information

Review PROCESS, decision making PROCESS and communication BY

Review PROCESS, decision making PROCESS and communication BY Review PROCESS, decision making PROCESS and communication BY ethics committee Dr. Reneega Gangadhar, Professor & Head Department of Pharmacology Govt. Medical college Trivandrum Outline Review process

More information

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines 1. Introduction The Canadian Cancer Clinical Trials Network (3CTN) will support a portfolio of academic clinical trials

More information

Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials

Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials Cognizant 20-20 Insights Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials The industry s Shared Investigator Platform significantly reduces the time and cost

More information

WCG ACADEMY COURSE OVERVIEW

WCG ACADEMY COURSE OVERVIEW WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations

More information

Stanford University IRB Guidance On Data and Tissue Repositories

Stanford University IRB Guidance On Data and Tissue Repositories Stanford University IRB Guidance On Data and Tissue Repositories Databases, registries (data banks), and repositories (tissue banks) all involve the collection and storage of information and/or biological

More information

SPTF Universal Standards for. Social Performance. Management. Version 2.0, Published August 2016

SPTF Universal Standards for. Social Performance. Management. Version 2.0, Published August 2016 SPTF Universal Standards for Social Performance Version 2.0, Published August 2016 Management Pathway to Improved Practice REPORT 5 1 LEARN Responsible Inclusive Finance 2 ASSESS IMPLEMENT 4 PLAN 3 The

More information

Ethical Principles in Clinical Research

Ethical Principles in Clinical Research Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies

More information

Expanded Access (including Emergency Use & Humanitarian Use Devices)

Expanded Access (including Emergency Use & Humanitarian Use Devices) Expanded Access (including Emergency Use & Humanitarian Use Devices) Bertha delanda, CIP IRB Training Specialist Research Compliance Office March 2012 What Is Expanded Access? Permits use of an investigational

More information

Production Assistance for Cellular Therapies PACT

Production Assistance for Cellular Therapies PACT Production Assistance for Cellular Therapies PACT Traci Heath Mondoro, PhD NHLBI Bethesda, Maryland Renewed PACT Program Renewed January 15, 2010 Scope and size expanded Cell Processing Facilities (CPFs)

More information

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use SJMHS Research Compliance Office Guidance Document Expanded Access to Investigational Drugs & Biologics for Treatment Use May 2015 1 Expanded Access to Investigational Drugs & Biologics for Treatment Use

More information